Physician profile
Joseph M Rosenblatt
NPI 1609031715
$45,559.35
in general payments reported to CMS, 2019-2025
22 companies · $27K in 2025
The $27K reported for 2025 was more than what 93% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,651 · 2020: $1,828 · 2021: $713 · 2022: $4,340 · 2023: $3,419 · 2024: $4,385 · 2025: $27K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $26K · Consulting Fee: $6,975 · Food and Beverage: $1,907 · Education: $14.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $26,129.54 |
| Consulting Fee | $6,975.00 |
| Food and Beverage | $1,907.48 |
| Education | $14.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $33,687.19 | 2021-2025 | Na |
| Stryker Corporation | $3,155.41 | 2019-2025 | Stryker Nav3i, Es2 Spinal System, Tritanium |
| Synthes USA Products LLC | $2,255.88 | 2022 | |
| Orthofix Medical, INC. | $1,990.60 | 2019-2020 | |
| Wishbone Medical INC. | $1,641.37 | 2022-2023 | |
| Zimmer Biomet Holdings, INC. | $755.27 | 2020 | |
| Depuy Synthes Sales INC. | $320.18 | 2022-2025 | Na |
| Vericel Corporation | $302.36 | 2023-2024 | Maci |
| Smith+Nephew, INC. | $269.82 | 2021-2024 | Spatial Frame, Smart Tsf |
| Alexion Pharmaceuticals, INC. | $247.13 | 2020-2025 | Strensiq |
| Miach Orthopaedics, INC. | $184.34 | 2025 | |
| Biomarin Pharmaceutical INC. | $160.34 | 2022-2024 | Voxzogo 1.2mg |
| Illuminoss Medical, INC. | $160.09 | 2024 | |
| Nuvasive Specialized Orthopedics, INC. | $118.18 | 2022 | |
| Wright Medical Technology, INC. | $90.29 | 2019 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Orthopediatrics Corp. | $58.38 | 2022 | |
| Acumed LLC | $54.58 | 2022 | |
| Alafair Biosciences, INC. | $40.40 | 2025 | Versawrap |
| Djo, LLC | $20.88 | 2023 | Donjoy |
| Lilly USA, LLC | $20.15 | 2019 | |
| Ultragenyx Pharmaceutical INC. | $13.93 | 2021 | |
| Next Science LLC | $12.58 | 2023 | Xperience, Blastx, Surgx |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Rosenblatt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.